Clinical Trials Browser

Phase 1/2 × INDUSTRY × ALX148 × Clear all

NCT07007559 2026-02-03

ASPEN-09

Phase 1/2 Recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT05027139 2025-10-16

A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer

Phase 1/2 Completed

HER2-expressing Cancers